Long-acting injectables (LAIs) are a relatively newer option for HIV treatment and prevention. Although injectable regimens may not be preferable to all patients due to fear of needles or limited transportation to the clinic, some people living with HIV (PLWH) may prefer infrequent injections rather than daily oral medications. Reasons for preferring LAIs can include challenges with adherence to oral medications or with stigma related to having these medications in their home. For patients facing these challenges, LAIs may significantly improve quality of life. Further, data continue to be published in different patient populations, showing that these injectable therapies remain safe and efficacious in a variety of patients.
Image credit: auremar | stock.adobe.com
LA Cabotegravir/Rilpivirine
LA cabotegravir/rilpivirine…